AGENDA
JOINT U.S.-JAPAN MEETING ON CHEMO-ENDOCRINE THERAPY OF BREAST CANCER
San Antonio, Texas, March 3 and 4, 1981
| March 2 1981 | ||
| 7:00- 9:00pm | REGISTRATION and INFORMAL RECEPTION | |
| March 3 1981 | ||
| 8:30- 8:45am | Welcome | Stephen Carter |
| 8:45- 9:00 | Administrative Matters | Hiroki Koyama William McGuire |
| 9:00- 9:30 | The Design and Interpretation of Trials Combining Drugs and Hormonal Therapy in Advanced Disease | Stephen Carter |
| 9:30- 10:00 | Endocrine and Combined Chemotherapy for Stage IV Breast Cancer | Olof Pearson |
| 10:00-10:30 | COFFEE | |
| 10:30- 11:00 | Adriamycin, Cyclophosphamide, and Ftorafur Combination for Advanced Breast Cancer | Makota Ogawa |
| 11:00- 11:30 | Chemo-endocrine Therapy for Advanced Breast Cancer | B.J. Kennedy |
| 11:30- 12:00 | Tamoxifen Combined with Cytotoxic Chemotherapy for Advanced Breast Cancer | Hiroki Koyama |
| 12:00- 12:30pm | Tamoxifen to Increase Chemosensitivity-tamoxifen ± Halotestin | M. Lippman |
| 12:30- 2:00 | LUNCH | |
| 2:00- 2:30 | Adriamycin, Cyclophosphamide, Tamoxifen Studies and Adrianycin, Cyclophosphamide, Caulesterone Studies in Advanced Breast Cancer | Frederick Ahmann |
| 2:30- 3:00 | Endocrine and Chemotherapy for Advanced Breast Cancer | Yasuo Nomura |
| 3:00- 3:30 | Tamoxifen Plus Sequential CMF versus Tamoxifen Alone in Post Menopausal Advanced Breast Cancer | John Glick |
| 3:30- 4:00 | Phase II Studies of Vindesine, mAMSA, and Tamoxifen for Advanced Breast Cancer | Makoto Ogawa |
| 4:00- 4:30 | Oophorectomy ± Chemotherapy in Premenopausal Advanced Breast Cancer | David Ahmann |
| 4:30- 5:00 | Oral High-dose Medroxyprogesterone Acetate in Advanced Breast Cancer | Masaru Izuo |
| 5:00- 5:30 | Adriamycin Treatment for Advanced Breast Cancer in Japan | Osahiko Abe |
| 6:30 | COCKTAILS and DINNER | |
| March 4, 1981 | ||
| 8:30- 9:00am | Impact of Steroidal and Antiestrogens upon Chemotherapy Results | Douglass Tormey |
| 9:00- 9:30 | Adjuvant Chemotherapy, Antiestrogen, and Immunotherapy for Stage II Breast Cancer | Charles Hubay |
| 9:30- 10:00 | Adjuvant Chemo-endocrine Therapy | Bernard Fisher |
| 10:00- 10:30 | COFFEE | |
| 10:30-11:00 | Adjuvant Chemo-endocrine Trials-pilot and Southwest Group | W.A. Knight |
| 11:00-11:30 | Multidisciplinary Treatment for Locally Advanced Breast Cancer | Hiroki Koyama |
| 11:30-12:00 | Endocrine Therapy and Disappearance of Hormone-dependency in Breast Cancer | Keishi Matsumoto |
| 12:00- 1:00pm | LUNCH | |
| 2:00- 2:30 | Hormone Receptors and Obesity | Keijuro Kuno |
| 2:30- 3:00 | Innovative Strategies for Chemo-endocrine Therapy | Kent Osborne |
| 3:00- 3:30 | Experimental Studies on Chemo-endocrine Therapy | Osahiko Abe |
| 3:30- 4:00 | Effects of Antiestrogen and Adriamycin on Cell Growth of a Human Breast Cancer Cell Line (MCF- 7) | Yasuo Nomura |
| 4:00- 4:30 | Predicting Response with Stem Cell Assay | Daniel Von Hoff |
| 4:30- 4:50 | Conference Summary | Stephen Carter |
PARTICIPANTS
JAPAN
Osahiko Abe, M.D.
Professor, Department of Surgery
Keio University Medical School
35 Shinanomachi
Shinjuku-ku, Tokyo 160
Masaru Izuo, M.D.
Professor, Department of Surgery
Gunma University Medical School
3-39-15 showa-cho
Maebashi, Gunma 371
Hiroki Koyama, M.D.
Chief, Department of Endocrine Surgery
The Center for Adult Diseases, Osaka
1-3-3 Nakamichi
Higashinari-ku, Osaka 537
Keijiro Kuno, M.D.
Chief, Department of Surgery
Cancer Institute Hospital
1-37-1 Kami-Ikebukuro
Toshima-ku, Tokyo 170
Keishi Matsumoto, M.D.
Professor, Department of Pathology
Osaka University Medical School
4-3-57 Nakanoshima
Kita-ku, Osaka 530
Yasuo Nomura, M.D.
Chief, Department of Breast Surgery
National Kyushu Cancer Center Hospital
595 Notame
Minami-ku, Fukuoka 815
Makoto Ogawa, M.D.
Chief
Division of Clinical Chemotherapy
Cancer Chemotherapy Center
Japanese Foundation for Cancer Research
1-37-1 Kami-Ikebukuro
Toshima-ku, Tokyo 170
UNITED STATES
David L. Ahmann, M.D.
Division of Medical Oncology
Breast Cancer
Mayo Clinic
Rochester, Minnesota 55901
Dr. Frederick Ahmann
Division of Oncology
Breast Cancer
University of Arizona Health Science Center
Tucson, Arizona 85724
Stephen K. Carter, M.D.
Director
Northern California Cancer Program
Post Office Box 10144
Palo Alto, California 94303
Bernard Fisher, M.D.
Department of Surgery
University of Pittsburgh
3550 Terrace Street
Scaife Hall, Room 914
Pittsburgh, Pennsylvania 15261
John Glick, M.D.
Hospital of the University of Pennsylvania
3400 Spruce Street
Philadelphia, Pennsylvania19104
Charles A. Hubay, M.D.
Project Director
University Hospitals of Cleveland
Wearn Building, Room 548
1065 Adelbert Road
Cleveland, Ohio 44106
B.J. Kennedy, M.D.
Medical Oncology
University of Minnesota Medical School
420 Delaware Street, S.E.
Minneapolis, Minnesota 55455
Daniel Kisner, M.D.
National Cancer Institute
Bethesda, Maryland 20205
W.A. Knight, M.D.
University of Texas Health Science Center
Department of Medicine/Oncology
7703 Floyd Curl Drive
San Antonio, Texas 78284
William L. McGuire, M.D.
Department of Medicine/Oncology
University of Texas Health Science Center at San Antonio
7703 Floyd Curl Drive
San Antonio, Texas 78284
C. Kent Osborne, M.D.
Department of Medicine/Oncology
University of Texas Health Science Center
7703 Floyd Curl Drive
San Antonio, Texas 78284
Olof Pearson, M.D.
Department of Medicine
Case Western Reserve University
Cleveland, Ohio 44106
Douglass C. Tormey, M.D.
Department of Human Oncology
Wisconsin Clinical Cancer Center
University of Wisconsin
600 Highland Avenue
Madison, Wisconsin 53792
Daniel Von Hoff, M.D.
Department of Medicine/Oncology
University of Texas Health Science Center
7703 Floyd Curl Drive
San Antonio, Texas 78284